Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: A meta-analysis of randomized controlled trials - Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)101-102
Number of pages2
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number3
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this